{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:41Z","timestamp":1786985441433,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Suzhou Ribo Life Science Co. Ltd.","award":["Ribo-HK001"],"award-info":[{"award-number":["Ribo-HK001"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU479111"],"award-info":[{"award-number":["HKBU479111"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU478312"],"award-info":[{"award-number":["HKBU478312"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU261113"],"award-info":[{"award-number":["HKBU261113"]}]},{"name":"Research Grants Council & Natural Science Foundation Council","award":["N_HKBU435\/12"],"award-info":[{"award-number":["N_HKBU435\/12"]}]},{"name":"Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS)","award":["489213"],"award-info":[{"award-number":["489213"]}]},{"name":"Natural Science Foundation Council","award":["81272045"],"award-info":[{"award-number":["81272045"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bone.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T23:50:24Z","timestamp":1384559424000},"page":"76-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation"],"prefix":"10.1016","volume":"59","author":[{"given":"Baosheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.M.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-7695","authenticated-orcid":false,"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.11.007_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures","volume":"118","author":"Khosla","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.11.007_bb0010","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bone.2013.11.007_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM200401083500219","article-title":"Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis","volume":"350","author":"Vegni","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.11.007_bb0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2013.11.007_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2013.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.11.007_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"Cosman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.11.007_bb0040","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb1760","article-title":"Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1","volume":"10","author":"Lu","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bone.2013.11.007_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/430161a","article-title":"The RNAi revolution","volume":"430","author":"Novina","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.11.007_bb0050","series-title":"IOF-ECCEO12 European Congress on Osteoporosis and Osteoarthritis, 21\u201324 March 2012, Bordeaux, France","article-title":"Increased CKIP-1 protein level negatively associates with decrease in both osteocalcin mRNA and Smad1\/5 protein levels in bone specimens from aging men","author":"Guo","year":"2012"},{"key":"10.1016\/j.bone.2013.11.007_bb0055","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1073\/pnas.0805434105","article-title":"Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates","volume":"105","author":"Frank-Kamenetsky","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.11.007_bb0060","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1007\/s00018-012-0998-1","article-title":"Multispecies-compatible antitumor effects of a cross-species small-interfering RNA against mammalian target of rapamycin","volume":"69","author":"Ahn","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bone.2013.11.007_bb0065","article-title":"Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis","author":"FDA","year":"1997"},{"key":"10.1016\/j.bone.2013.11.007_bb0070","series-title":"Guidelines for preclinical evaluation and clinical trials in osteoporosis","author":"WHO","year":"1998"},{"key":"10.1016\/j.bone.2013.11.007_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2013.11.007_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.02.012","article-title":"The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats","volume":"55","author":"Peng","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.11.007_bb0085","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1093\/nar\/gkg649","article-title":"The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides","volume":"31","author":"Kretschmer-Kazemi Far","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bone.2013.11.007_bb0090","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1074\/jbc.M210326200","article-title":"Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis","volume":"278","author":"Vickers","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.11.007_bb0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bone.2013.11.007_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature06179","article-title":"Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway","volume":"449","author":"John","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.11.007_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbrc.2007.10.012","article-title":"Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs","volume":"364","author":"Shin","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.11.007_bb0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.11.007_bb0115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbrc.2006.11.059","article-title":"Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule","volume":"352","author":"Furset","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.11.007_bb0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nbt0806-951","article-title":"All in the RNA family","volume":"24","author":"Davidson","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bone.2013.11.007_bb0125","first-page":"23429","article-title":"Molecular basis for the immunostimulatory potency of small interfering RNAs","volume":"2006","author":"Sioud","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.bone.2013.11.007_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.lfs.2006.11.037","article-title":"Low-intensity pulsed ultrasound stimulates osteogenic differentiation in ROS 17\/2.8 cells","volume":"80","author":"Takayama","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.bone.2013.11.007_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","article-title":"Transcription factors controlling osteoblastogenesis","volume":"473","author":"Marie","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bone.2013.11.007_bb0140","doi-asserted-by":"crossref","first-page":"12600","DOI":"10.1073\/pnas.202296599","article-title":"Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner","volume":"99","author":"Bancroft","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.11.007_bb0145","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.biomaterials.2004.09.050","article-title":"Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate","volume":"26","author":"Shin","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2013.11.007_bb0150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0185(199812)252:4<554::AID-AR6>3.0.CO;2-2","article-title":"Morphological and immunocytochemical characterization of primary osteogenic cell cultures derived from fetal rat cranial tissue","volume":"252","author":"Irie","year":"1998","journal-title":"Anat Rec"},{"key":"10.1016\/j.bone.2013.11.007_bb0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1373\/clinchem.2007.094953","article-title":"Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis","volume":"54","author":"Garnero","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2013.11.007_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365519950185850","article-title":"Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma","volume":"59","author":"Diaz-Martin","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.bone.2013.11.007_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2009.11.013","article-title":"Non-viral nanosystems for systemic siRNA delivery","volume":"62","author":"David","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bone.2013.11.007_bb0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00223-009-9312-0","article-title":"Specific binding and mineralization of calcified surfaces by small peptides","volume":"86","author":"Yarbrough","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.11.007_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/ar50092a003","article-title":"Synthetic amorphous calcium phosphate and its relation to bone mineral structure","volume":"8","author":"Posner","year":"1975","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bone.2013.11.007_bb0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.11.007_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.11.007_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1302\/0301-620X.94B3.27999","article-title":"Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals","volume":"94","author":"Thompson","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.bone.2013.11.007_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bone.2013.11.007_bb0200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cellsig.2006.11.002","article-title":"The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling","volume":"19","author":"Zhang","year":"2007","journal-title":"Cell Signal"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213004432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213004432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:38:21Z","timestamp":1757612301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213004432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":40,"alternative-id":["S8756328213004432"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.11.007","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}